Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc. (GALT)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
4. 18
-0.05
-1.182%
$
351.68M Market Cap
- P/E Ratio
- Div Yield
413,700 Volume
-0.66 Eps
$ 4.23
Previous Close
Add Transaction
Day Range
4.14 4.42
Year Range
2.03 7.13
Want to track GALT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Galectin Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
YA
Yinka Akinsola Blue Trust Inc.
7,000 $10,610 $33,845 $23,235 218.99%
SE
Sima Elimelech Activest Wealth Management
2,000 $4,520 $9,520 $5,000 110.62%
RF
Rekah Franca Catalyst Funds Management Pty Ltd.
22,500 $62,775 $109,575 $46,800 74.55%
CAL
CoreCap Advisors LLC CoreCap Advisors LLC
3,890 $9,669.66 $18,885.95 $9,216.29 95.31%
NB
Nolan Baker Retirement Guys Formula LLC
187,062 $385,404.06 $866,097.06 $480,693 124.72%
Belena Vincetti
Belena Vincetti Fortis Capital Advisors LLC
106,139 $441,538 $480,809.67 $39,271.67 8.89%
HFT
Hui Fai Tam Caitong International Asset Management Co. Ltd.
7 $20 $31.15 $11.15 55.75%
Kevin Kroskey
Kevin Kroskey True Wealth Design LLC
2 $3.37 $9.52 $6.15 182.49%
Donald Hatcher
Donald Hatcher Solutions 4 Wealth, Ltd
25,027 $41,544.75 $106,489.88 $64,945.13 156.33%
Elizabeth Arce
Elizabeth Arce Sovran Advisors LLC
257,830 $576,073.61 $1.13M $553,221.79 96.03%
Adam Scott
Adam Scott Argyle Capital Partners LLC
13,375 $17,254 $56,843.75 $39,589.75 229.45%